Cardinal Health, Inc. (CAH) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail c...
Cardinal Health, Inc.'s revenue decreased 1.9% year over year, from $226.83B to $222.58B.
Net income increased 83.2% over the same period, from $852.0M to $1.56B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 83% in total.
Total debt increased by 67.5% to $8.53B.
Operating cash flow declined 36.3% to $2.40B.
Cardinal Health, Inc. maintains a moderate net profit margin of 0.7%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2024 | $112.21B+104.9% | $358.0M | $3.61B | $468.0M | $1.73B | $46.57B | $4.72B | $-3.45B |
| Q3 FY2024 | $167.12B+48.9% | $616.0M | $5.56B | $835.0M | $1.69B | $45.88B | $5.85B | $-3.27B |
| Q1 FY2025 | $52.28B-68.7% | $416.0M | $1.90B | $568.0M | $-1.65B | $43.06B | $5.16B | $-3.28B |
| Q2 FY2025 | $107.54B+105.7% | $816.0M | $3.84B | $1.12B | $-2.05B | $47.00B | $7.61B | $-2.99B |
| Q3 FY2025 | $162.42B+51.0% | $1.32B | $5.97B | $1.85B | $870.0M | $49.87B | $7.68B | $-2.95B |
| Q1 FY2026 | $64.01B-60.6% | $450.0M | $2.32B | $668.0M | $973.0M | $55.23B | $9.03B | $-2.88B |
| Q2 FY2026 | $129.64B+102.5% | $917.0M | $4.72B | $1.38B | $1.66B | $58.08B | $9.03B | $-2.88B |
| Q3 FY2026 | $190.58B+47.0% | $1.32B | $7.21B | $1.88B | $3.48B | $56.69B | $8.92B | $-2.83B |
Balance Sheet Summary (Latest Period)
Total Assets
$53.12B
Total Liabilities
$55.90B
Total Equity
$-2.78B
Cash & Equivalents
$3.87B
Total Debt
$8.53B
Current Assets
$36.37B
Current Liabilities
$38.90B
Retained Earnings
$783.0M